Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria

医学 米兰标准 肝细胞癌 肝移植 内科学 危险系数 胃肠病学 优势比 置信区间 单变量分析 甲胎蛋白 阶段(地层学) 移植 终末期肝病模型 多元分析 古生物学 生物
作者
Bilal Hameed,Neil Mehta,Gonzalo Sapisochín,John P. Roberts,Francis Y. Yao
出处
期刊:Liver Transplantation [Lippincott Williams & Wilkins]
卷期号:20 (8): 945-951 被引量:236
标识
DOI:10.1002/lt.23904
摘要

Serum alpha-fetoprotein (AFP) has been increasingly recognized as a marker for a poor prognosis after liver transplantation (LT) for hepatocellular carcinoma (HCC). Many published reports, however, have included a large proportion of patients with HCC beyond the Milan criteria, and the effects of incorporating AFP as an exclusion criterion for LT remain unclear. We studied 211 consecutive patients undergoing LT for HCC within the Milan criteria according to imaging under the Model for End-Stage Liver Disease organ allocation system between June 2002 and January 2009. The majority (93.4%) had locoregional therapy before LT. The median follow-up was 4.5 years (minimum = 2 years). The Kaplan-Meier 1- and 5-year patient survival rates were 94.3% and 83.4%, respectively. In a univariate analysis, significant predictors of HCC recurrence included vascular invasion [hazard ratio (HR) = 10, 95% confidence interval (CI) = 3.9-26, P < 0.001], a pathological tumor stage beyond the University of California San Francisco criteria (HR = 4.1, 95% CI = 1.36-12.6, P = 0.01), an AFP level > 1000 ng/mL (HR = 4.5, 95% CI = 1.3-15.3, P = 0.02), and an AFP level > 500 ng/mL (HR = 3.1, 95% CI = 1.04-9.4, P = 0.04). In a multivariate analysis, vascular invasion was the only significant predictor of tumor recurrence (HR = 5.6, 95% CI = 1.9-19, P = 0.02). An AFP level > 1000 ng/mL was the strongest pretransplant variable predicting vascular invasion (odds ratio = 6.8, 95% CI = 1.6-19.1, P = 0.006). The 1- and 5-year rates of survival without recurrence were 90% and 52.7%, respectively, for patients with an AFP level > 1000 ng/mL and 95% and 80.3%, respectively, for patients with an AFP level ≤ 1000 ng/mL (P = 0.026). Applying an AFP level > 1000 ng/mL as a cutoff would have resulted in the exclusion of 4.7% of the patients from LT and a 20% reduction in HCC recurrence. In conclusion, an AFP level > 1000 ng/mL may be a surrogate for vascular invasion and may be used to predict posttransplant HCC recurrence. Incorporating an AFP level > 1000 ng/mL as an exclusion criterion for LT within the Milan criteria may further improve posttransplant outcomes. Liver Transpl 20:945-951, 2014. © 2014 AASLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
kelly发布了新的文献求助10
刚刚
1秒前
一鸣大人完成签到,获得积分10
1秒前
爆米花应助111采纳,获得30
1秒前
852应助幼汁汁鬼鬼采纳,获得10
2秒前
2秒前
泡泡糖发布了新的文献求助10
2秒前
桐桐应助啊哈哈哈哈采纳,获得10
3秒前
3秒前
卡列宁的微笑完成签到,获得积分10
3秒前
3秒前
博士伦666完成签到 ,获得积分10
4秒前
4秒前
4秒前
冷酷的小之完成签到,获得积分10
5秒前
CodeCraft应助毛毛采纳,获得10
5秒前
ztayx完成签到 ,获得积分10
5秒前
Wshtiiiii发布了新的文献求助10
5秒前
6秒前
TomatoPan完成签到,获得积分10
6秒前
Singularity应助yyl采纳,获得10
6秒前
tanglu完成签到,获得积分10
6秒前
gjm发布了新的文献求助10
6秒前
eka123发布了新的文献求助10
8秒前
一缕炊烟照月明完成签到,获得积分10
8秒前
科研小白发布了新的文献求助10
8秒前
birdy发布了新的文献求助10
8秒前
wang发布了新的文献求助10
8秒前
Ale发布了新的文献求助10
8秒前
9秒前
leo_zjm完成签到,获得积分10
9秒前
orixero应助猪猪hero采纳,获得10
9秒前
俞藏今发布了新的文献求助10
10秒前
丘比特应助年轻半雪采纳,获得10
10秒前
CR7应助兰蕙采纳,获得20
11秒前
小李完成签到,获得积分20
11秒前
11秒前
11秒前
CipherSage应助自信的董博采纳,获得10
11秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974712
求助须知:如何正确求助?哪些是违规求助? 3519159
关于积分的说明 11197254
捐赠科研通 3255257
什么是DOI,文献DOI怎么找? 1797724
邀请新用户注册赠送积分活动 877130
科研通“疑难数据库(出版商)”最低求助积分说明 806132